Ontology highlight
ABSTRACT: Background
People with head and neck cancer have higher comorbidity levels but it remains unclear if pretreatment comorbidity is an independent prognosticator in head and neck cancer.Methods
Survival analyses were performed using data from participants in a UK multicentre cohort study with cancers of the oral cavity (n = 668), oropharynx (n = 1074), and larynx (n = 530). Survival analyses were incrementally adjusted for age, sex, marital status, income, education, stage, alcohol, and smoking.Results
After adjusting for demographic, clinical, and behavioral confounders, higher baseline comorbidity was associated with reduced overall survival (mild comorbidity HR = 1.4, 95% CI = 1.1, 1.7; moderate comorbidity HR = 1.7, 95% CI = 1.3, 2.2; severe comorbidity HR = 2.8, 95% CI = 1.9, 4.; P-trend<.001).Conclusions
Our findings suggest that comorbidity is an independent prognosticator for overall survival in head and neck cancer. Comorbid illnesses should be considered in the assessment and treatment planning of people with head and neck cancer.
SUBMITTER: Schimansky S
PROVIDER: S-EPMC6890487 | biostudies-literature | 2019 Apr
REPOSITORIES: biostudies-literature
Schimansky Sarah S Lang Samantha S Beynon Rhona R Penfold Christopher C Davies Amy A Waylen Andrea A Thomas Steve S Pring Miranda M Pawlita Michael M Waterboer Tim T Ness Andy A
Head & neck 20181214 4
<h4>Background</h4>People with head and neck cancer have higher comorbidity levels but it remains unclear if pretreatment comorbidity is an independent prognosticator in head and neck cancer.<h4>Methods</h4>Survival analyses were performed using data from participants in a UK multicentre cohort study with cancers of the oral cavity (n = 668), oropharynx (n = 1074), and larynx (n = 530). Survival analyses were incrementally adjusted for age, sex, marital status, income, education, stage, alcohol, ...[more]